Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-07-28
1999-07-13
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
A61K 3156
Patent
active
059227010
ABSTRACT:
The present invention is related to a method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue. Examples of re-epithelialization in which the invention is particularly suited include, but are not limited to, re-epithelialization of (a) skin following surgical wounds, (b) skin abrasions caused by mechanical trauma, caustic agents or burns, (c) cornea following cataract surgery or corneal transplants, (d) mucosal epithelium (respiratory, gastrointestinal, genitourinary, mammary, oral cavity, ocular tissue, liver and kidney) following infection, nonpathological etiologies or drug therapy, (e) skin following grafting and (f) renal tubule following acute tubular necrosis. Examples of re-endothelialization in which the invention is particularly suited include, but are not limited to, re-endothelialization (or regrowth of endothelium) in blood vessels following angioplasty, and the lysis of fibrin clots or lysis or mechanical disruption of thrombi in coronary arteries. In accordance with the present invention, the time to complete re-epithelialization or re-endothelialization is enhanced or accelerated by administering a dehydroepiandrosterone (DHEA) derivative.
REFERENCES:
patent: 4898694 (1990-02-01), Schwartz et al.
patent: 5001119 (1991-03-01), Schwartz et al.
patent: 5110810 (1992-05-01), Eich et al.
patent: 5162198 (1992-11-01), Eich et al.
patent: 5175154 (1992-12-01), Schwartz et al.
patent: 5489581 (1996-02-01), Daynes et al.
patent: 5532230 (1996-07-01), Daynes et al.
patent: 5587369 (1996-12-01), Daynes et al.
patent: 5635496 (1997-06-01), Daynes et al.
patent: 5686438 (1997-11-01), Daynes et al.
"Morphometric analysis of human epidermis treated with testosterone and dehydroepiandrosterone in organ culture," R. Tammi et al., Arch Dermatol Res (1989) 281:417-423.
"Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women," P. Diamond et al., Journal of Endocrinology (1996) 150, S43-S50.
"Dehydroepiandrosterone Reduces Progressive Dermal Ischemia Caused by Thermal Injury," Barbara A. Araneo et al., Journal of Surgical Research 59 (1995),pp. 250-262.
"The Local Action of Adrenocortical Steroids on Epidermis and Connective Tissue of the Skin," C. William Castor et al., vol. 47, Oct. 1950, pp. 234-241, Dept of Anatomy, Univ. of Michigan Med. Sch., Ann Arbor, Michigan.
"Dehydroepiandrostereone: An Anti-Cancer and Possible Anti-aging Substnace," Arthur G. Schwartz, et al. Intervention in the Aging Process, Part A: Quantitation, Epidemiology, and Clinical Research, 1983 Alan R. Liss, Inc., pp. 267-278.
"Dehydroepiandrosterone and Related Steroids Induce Multilamellar Lipid Structures in Cultured Human Endothelial Cells," Milton M. Sholley et al., American Journa of Pathology, vol. 136, No. 5, May 1990, pp. 1187-1198.
Henley III Raymond
University of Utah Research Foundation
LandOfFree
Method for enhancing or accelerating re-epithelialization or re- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing or accelerating re-epithelialization or re-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing or accelerating re-epithelialization or re- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2275864